An ultrasound test that detected 96 per cent of ovarian cancers in postmenopausal women should replace current standard of care test in the UK according to...
A researcher from the University of Oxford has received new funding to study the role of neutrophils in ovarian cancer. Neutrophils are important cells in the...
Women’s cancer innovations will take centre stage at the second edition of the Femtech World Awards. The second annual Femtech World Awards aim to shine a...
One in four women with the most aggressive form of ovarian cancer could receive an earlier diagnosis if they were tested and fast-tracked for specialist care,...
Women with ovarian cancer whose fallopian tubes are removed during sterilisation via laparoscopy have only marginally more surgical complications than those whose tubes are simply cut,...
Treatment with the iron-binding drug deferiprone elicits a natural killer cell response in a preclinical model of ovarian cancer
The risk of developing ovarian cancer could jump about fourfold among women with endometriosis compared with women without the condition, a new study has found. A...
The US Food and Drug Administration (FDA) has approved Shorla Oncology’s new drug application for TEPYLUTE, a new formulation to treat breast and ovarian cancer. The...
Ovarian cancer has one of the lowest survival rates of any cancer in Australia
Ovarian cancer causes more deaths than any other gynaecologic malignancy
